Evolution Advisers’s Eli Lilly LLY Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q3
– Sell
-3
Closed -$3K – 510
2026
Q2
$3K Buy
+3
New +$3.06K ﹤0.01% 161
2022
Q1
– Sell
-75
Closed -$20K – 156
2021
Q4
$20K Buy
+75
New +$19K 0.01% 76

Other funds holding LLY

Evolution Advisers's LLY Position: Q3 2026 in Review

Evolution Advisers sold out of Eli Lilly (LLY) in Q3 2026, closing a stake of 3 shares — an estimated $3K sold.

Evolution Advisers first reported a position in LLY in Q4 2021 and held it in 2 quarters. The position peaked at $20K in Q4 2021. 4,631 funds tracked by Wall St. Rank hold LLY as of Q3 2026.

  • Evolution Advisers reported no remaining Eli Lilly position as of Q3 2026 after selling out during the quarter.
  • Evolution Advisers sold 3 Eli Lilly shares in Q3 2026, an estimated $3K.
  • Evolution Advisers first reported a position in Eli Lilly in Q4 2021 and held it in 2 quarters.
  • Evolution Advisers's Eli Lilly position peaked at $20K in Q4 2021.
  • 4,631 funds tracked by Wall St. Rank held Eli Lilly as of Q3 2026.

Based on Evolution Advisers's 13F filing for Q3 2026, filed 6 Nov 2026.